However, our data indicated that the impact of ALDH2 rs671 on cancer development in Japanese HBOC patients are marginal, and the ALDH2 variant neither prevents nor accelerates the initiation and progression of breast cancer. Here, ALDH2 is linked to breast carcinoma.